A multi-center phase II research with Tc-99m MIP-1404 in 100 individuals was lately completed, and the info were presented at 2014 SNMMI Annual Getting together with in St. Louis, Mo. Progenics Pharmaceuticals has programs to conduct a stage III trial soon.. Breakthrough study displays novel molecular imaging drug to detect early prostate cancer Breakthrough study displays potential of fresh drug used in combination with planar and SPECT imaging A novel research demonstrates the potential of a novel molecular imaging drug to detect and visualize early prostate cancer in gentle tissue, lymph bone and nodes.Unlike first-generation traits, which often consist of a single gene per trait, today's biotech traits under development often pair multiple genes with multiple promoters to produce favorable characteristics. However, creating the thousands of combos of genes and promoters that must identify the perfect candidates is time-consuming and costly, and offers eluded even the most robust trait development pipelines often. ICODE helps solve this matter by providing a competent, high-throughput approach. Related StoriesResearchers identify inherited gene variation connected with pediatric acute lymphoblastic leukemiaResearchers determine tumor suppressor genes that travel subset of melanomasCHOP researchers delay symptoms, extend lifespan in animal model of Batten diseaseThe iCODE system is the latest in a line of improvements from Ceres.